LAVAL, Quebec and PITTSBURGH, Pa., Feb.
23, 2017 /PRNewswire/ -- Valeant Pharmaceuticals
International, Inc.'s (NYSE: VRX and TSX: VRX) ("Valeant" or the
"Company") wholly owned subsidiary Obagi Medical Products, a
long-time leader in professional skin care, today announced a
collaboration with Nextcell Medical Company to claim exclusive
distribution of Suzan Obagi, M.D.'s
line of skin care products throughout the
United States.
Established in 2013 with renowned cosmetic surgeon and
dermatologist, Suzan Obagi, M.D.,
Nextcell Medical has been diligently working on new innovations
that will change the industry's approach to skin care. In their
strategic relationship, Obagi and Nextcell have joined forces to
introduce a next generation line of clinical skin care products.
Obagi intends to continue to invest in Nextcell's research and
development efforts.
"I am so excited to finally unveil my line alongside the
Obagi® line of products," said Suzan Obagi, M.D. "We have been working long and
hard on designing a new concept of skin care for the modern
patient. With our visions aligned, I can't think of a better
company than Obagi to introduce our products."
"The relationship between Obagi and Nextcell is a forward move
for this important brand," said Joseph C.
Papa, Chairman and CEO of Valeant. "Dr. Suzan Obagi brings extensive academic and
clinical experience to the rich history of Obagi."
"We are thrilled to have the opportunity to work with Obagi and
continue to build on the brand's already strong reputation and
unsurpassed brand recognition," stated Mazen F. Youssef, President and CEO of Nextcell.
"We are confident our collaboration will accelerate the growth of
both companies and complete Obagi's portfolio with Dr. Obagi's
novel innovations."
The U.S. launch of Suzan Obagi,
M.D.'s line for Obagi is anticipated for mid-year of 2017.
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a
multinational specialty pharmaceutical company that develops,
manufactures and markets a broad range of pharmaceutical products
primarily in the areas of dermatology, gastrointestinal disorders,
eye health, neurology and branded generics. More information about
Valeant can be found at www.valeant.com.
About Obagi Medical Products, Inc.
Obagi Medical Products is a global specialty pharmaceutical
company founded by leading skin care experts in 1988, and is now a
division of Valeant Pharmaceuticals North America LLC. Obagi
products are designed to help minimize the appearance of premature
skin aging, skin damage, hyperpigmentation, acne, and sun damage
and are primarily available through dermatologists, plastic
surgeons, medical spas, and other skin care
professionals. www.obagi.com
About Nextcell Medical Company
Nextcell was established in 2013, specializing in the research
and development of clinical skin care products. Under the
scientific and medical leadership of Suzan
Obagi, M.D., the company aimed to develop a skin care line
that met the demands of the modern patient. Each product created by
Dr. Suzan Obagi and Nextcell is
formulated according to a strict set of standards. Every ingredient
in each product is carefully evaluated and has a decided function
and purpose in the product formulation. From product ideation to
final production, Nextcell takes great care in seeing that each
product is supported by scientific research. Nextcell Medical is
headquartered in Pittsburgh,
Pennsylvania, USA, www.nextcellmedical.com.
About Suzan Obagi,
M.D.
Suzan Obagi, M.D. is an associate
professor of dermatology and plastic surgery at the University of Pittsburgh Medical Center (UPMC) and
serves as the director of the state-of-the-art UPMC Cosmetic
Surgery and Skin Health Center. Dr. Obagi's academic
commitments include clinical research, training residents in
dermatologic surgery & cosmetic dermatologic surgery, and in
her role as the director of the cosmetic dermatologic surgery
fellowship. Dr. Obagi has worked on various committees with the
American Society for Dermatologic Surgery, is the Secretary of the
Board of the American Academy of Cosmetic Surgery, has formerly
served as vice president of the American Board of Cosmetic Surgery,
and is a past president of the Cosmetic Surgery Foundation. In
addition, Dr. Obagi trains physicians from around the world on the
latest in cosmetic and laser surgery.
Forward-looking Statements
This press release contains forward-looking statements which may
generally be identified by the use of the words "anticipates,"
"expects," "intends," "plans," "should," "could," "would," "may,"
"will," "believes," "estimates," "potential," "target," or
"continue" and variations or similar expressions. Examples of such
forward-looking statements include, but are not limited to, the
industry's approach to skin care, investments in future research
and development efforts, and the expected growth of Obagi Medical
Products and Nextcell Medical. These statements are based upon the
current expectations and beliefs of management and are subject to
certain risks and uncertainties that could cause actual results to
differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, risks and uncertainties discussed in the Company's most
recent annual or quarterly report and detailed from time to time in
Valeant's other filings with the Securities and Exchange Commission
and the Canadian Securities Administrators, which factors are
incorporated herein by reference. Readers are cautioned not to
place undue reliance on any of these forward-looking statements.
These forward-looking statements speak only as of the date hereof.
Valeant undertakes no obligation to update any of these
forward-looking statements to reflect events or circumstances after
the date of this press release or to reflect actual outcomes,
unless required by law.
Contact Information:
Valeant
|
Obagi
Medical
|
Elif
McDonald
|
Dawn
Maniglia
|
514-856-3855
|
212-453-2064
|
877-281-6642 (toll
free)
|
d.magniglia@vegarun.com
|
elif.mcdonald@valeant.com
|
|
Media:
|
Nextcell
Medical
|
Renée Soto
Or
|
Haley
Stutz
|
Chris Kittredge/Jared
Levy
|
Director, Product
Development
|
Sard Verbinnen &
Co.
|
412-661-1600
|
212-687-8080
|
hstutz@nextcellmedical.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/obagi-medical-products-announces-collaboration-with-suzan-obagi-md-and-nextcell-medical-to-introduce-new-line-of-products-300412275.html
SOURCE Valeant Pharmaceuticals International, Inc.